LUNAC THERAPEUTICS LIMITED
LiquidationCompany number 11317849
London · Incorporated 18 April 2018
29 Craven Street, London, WC2N 5NT
Last updated on 18 September 2026
Other research and experimental development on natural sciences and engineering · SIC 72190
Company overview
LUNAC THERAPEUTICS LIMITED (company number 11317849) is a private limited company incorporated on 18 April 2018. It is currently in liquidation, with its registered office at 29 Craven Street, London WC2N 5NT. The company has a history of insolvency and filed a voluntary statement of affairs and notice of appointment of a liquidator on 28–29 May 2026. A Gazette notice regarding compulsory strike-off was issued on 28 April 2026.
The company’s principal activity is research and experimental development on natural sciences and engineering (SIC 72190). It has filed small company accounts up to 31 May 2024. Confirmation statements are overdue.
The current directors are Dr Peter Michael Finan, Dr Mary Eugenie Canning, Professor Helen Philippou, and Dr Mervyn Turner. Several previous directors have resigned, including Andrew John Michael Duley, Dr Sarah Jane Jarmin, and Julian David Howell. The persons with significant control are Epidarex Capital III UK LP (active) and the now-ceased Caribou Property Ltd.
A charge was created in November 2023. The company has an insolvency history and is no longer in active trading.
Compliance
Financial snapshot
Detailed figures (assets, liabilities, net worth) are available in the full credit report.
Officers
No officers on record.
Persons with significant control
Funding
4 funding roundsFiling history
No filings match this type.
Risk at a glance
- Company active
- Accounts up to date
- Confirmation statement up to date
- No insolvency history
- No registered charges
- Credit score
- Recommended limit
- Payment risk
Get the complete credit report
- Detailed financial statements
- Credit score & payment risk
- CCJs, charges & insolvency checks
- Recommended credit limit
Secure checkout · Report delivered instantly